About
HERVolution Therapeutics develops immunotherapies targeting human endogenous retroviruses (HERVs) to treat aging-related diseases, including cancer, metabolic disorders, and neurodegenerative conditions.
Explore HERVolution Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.